Journal Home
Search for

Volume 102, Issue 12, Pages 1681-1693 (December 2008)


View previous. 2 of 25 View next.

Achieving asthma control in practice: Understanding the reasons for poor control

John HaughneyaCorresponding Author Informationemail address, David Pricea, Alan Kaplanb, Henry Chrystync, Rob Horned, Nick Maye, Mandy Moffata, Jennifer Versnelf, Eamonn R. Shanahang, Elizabeth V. Hillyerh, Alf Tunsäteri, Leif Bjermeri

Received 17 July 2008; accepted 8 August 2008. published online 24 September 2008.

Summary 

Achieving asthma control remains an elusive goal for the majority of patients worldwide. Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this requires returning to the basics of history taking and physical examination, in conjunction with lung function measurement when appropriate. A number of factors may contribute to sub-optimal asthma control. Concomitant rhinitis, a common co-pathology and contributor to poor control, can often be identified by asking a simple question. Smoking too has been identified as a cause of poor asthma control. Practical barriers such as poor inhaler technique must be addressed. An appreciation of patients' views and concerns about maintenance asthma therapy can help guide discussion to address perceptual barriers to taking maintenance therapy (doubts about personal necessity and concerns about potential adverse effects). Further study into, and a greater consideration of, factors and patient characteristics that could predict individual responses to asthma therapies are needed. Finally, more clinical trials that enrol patient populations reflecting the real world diversity of patients seen in clinical practice, including wide age ranges, presence of comorbidities, current smoking, and differing ethnic origins, will contribute to better individual patient management.

a Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen AB25 2AY, Scotland, UK

b Chairperson, Family Physician Airways Group of Canada, Family Physician, 17 Bedford Park Avenue, Richmond Hill, Ontario, Canada L4C 2N9

c School of Applied Sciences, University of Huddersfield, Huddersfield, West Yorkshire HD1 3DH, UK

d Centre for Behavioural Medicine, Department of Policy & Practice, The School of Pharmacy, University of London, Mezzanine Floor, BMA House, Tavistock Square, London WC1H 9JP, UK

e Healthcare Practice Europe, Middle East, Africa, Hill & Knowlton, 20 Soho Square, London W1A 1PR, UK

f Research & Policy, Asthma UK, Summit House, 70 Wilson Street, London EC2A 2DB, UK

g Farranfore Medical Centre, Farranfore, Killarney, Co. Kerry, Ireland

h Respiratory Research Ltd., Unit 8, Beech Avenue, Taverham, Norwich NR8 6HW, UK

i Department of Respiratory Medicine & Allergology, University Hospital, 221 85 Lund, Sweden

Corresponding Author InformationCorresponding author. Tel.: +44 1355 261666; fax: +44 1224 550683.

PII: S0954-6111(08)00294-1

doi:10.1016/j.rmed.2008.08.003


View previous. 2 of 25 View next.